# Dexmedetomidine Prevents Postoperative Delirium After Deep Brain Stimulation in Patients With Parkinson's Disease

> **NCT05197439** · NA · UNKNOWN · sponsor: **Beijing Tiantan Hospital** · enrollment: 192 (estimated)

## Conditions studied

- Dexmedetomidine
- Postoperative Delirium
- Deep Brain Stimulation

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** 0.9% saline

## Key facts

- **NCT ID:** NCT05197439
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-01
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 192 (ESTIMATED)
- **Last updated:** 2023-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05197439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05197439, "Dexmedetomidine Prevents Postoperative Delirium After Deep Brain Stimulation in Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT05197439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*